Skip to content
5 mgBP 667

Drawing based on the label description. No photo yet.

5 mg BP 667 pill

Pill with imprint 5 mg BP 667 is red, capsule, 14 mm and has been identified as Tacrolimus Capsules 5 mg. It is supplied by Belcher Pharmaceuticals,llc.

Tacrolimus Capsules 5 mg

Imprint
5 mg BP 667
Strength
5 mg
Color
Red
Shape
Capsule / oblong
Size
14 mm
Score
No score line
Form
Capsule
Manufacturer
Belcher Pharmaceuticals,llc
NDC
62250-667, 62250-667-02

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Tacrolimus Capsules pills and guides

What is Tacrolimus Capsules used for?

Official uses from the US prescribing label

Prophylaxis of Organ Rejection in Kidney Transplant

Tacrolimus Capsules is indicated for the prophylaxis of organ rejection in patients receiving allogeneic kidney transplants. It is recommended that tacrolimus be used concomitantly with azathioprine or mycophenolate mofetil (MMF) and adrenal corticosteroids. Therapeutic drug monitoring is recommended for all patients receiving tacrolimus.

Prophylaxis of Organ Rejection in Liver Transplant

Tacrolimus Capsules is indicated for the prophylaxis of organ rejection in patients receiving allogeneic liver transplants. It is recommended that tacrolimus be used concomitantly with adrenal corticosteroids. Therapeutic drug monitoring is recommended for all patients receiving tacrolimus.

Prophylaxis of Organ Rejection in Heart Transplant

Tacrolimus Capsules is indicated for the prophylaxis of organ rejection in patients receiving allogeneic heart transplants. It is recommended that tacrolimus capsules be used concomitantly with azathioprine or mycophenolate mofetil (MMF) and adrenal corticosteroids. Therapeutic drug monitoring is recommended for all patients receiving tacrolimus capsules.

Limitations of Use

Tacrolimus Capsules should not be used simultaneously with cyclosporine.

Use with sirolimus is not recommended in liver and heart transplant. The safety and efficacy of tacrolimus with sirolimus has not been established in kidney transplant.

Intravenous use reserved for patients who cannot tolerate capsules orally.

From the FDA-approved label on DailyMed (published Oct 06, 2023).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • Your pill shows 5 mg BP 667. The parts can be split between the two sides, so turn the pill over and check both.
  • It is red, capsule, 14 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Sold under the brand name Tacrolimus.

Ingredients

Active: Tacrolimus

Inactive: Anhydrous Lactose, Hypromellose 2208 (100 Mpa.s), Croscarmellose Sodium, Magnesium Stearate, Gelatin, Titanium Dioxide, Ferric Oxide Red, Shellac, Dimethicone, Hydrated Silica

Other pills with imprint 5 mg BP 667

Same imprint, different listing. Check the color, size and maker against your pill.

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Tacrolimus Capsules pills